Wound Care News and Research

RSS
Derma Sciences’ MEDIHONEY HCS dressings receive CE Mark

Derma Sciences’ MEDIHONEY HCS dressings receive CE Mark

Full results from Derma Sciences’ DSC127 Phase 2 trial on diabetic foot ulcers

Full results from Derma Sciences’ DSC127 Phase 2 trial on diabetic foot ulcers

HCHD to offer APTA-accredited post-professional physical therapy residency programs

HCHD to offer APTA-accredited post-professional physical therapy residency programs

Hospitalization rates in NYC for patients with CA-MRSA more than tripled between 1997-2006

Hospitalization rates in NYC for patients with CA-MRSA more than tripled between 1997-2006

SVS, Elsevier to launch Journal of Vascular Surgery

SVS, Elsevier to launch Journal of Vascular Surgery

EWMA: International consensus on appropriate usage of silver dressings in wound care launched

EWMA: International consensus on appropriate usage of silver dressings in wound care launched

Covalon second quarter revenue increases to $1,090,038

Covalon second quarter revenue increases to $1,090,038

New medicine can start and hasten healing of diabetic and other chronic sores

New medicine can start and hasten healing of diabetic and other chronic sores

Mediaplanet publishes Wound Care

Mediaplanet publishes Wound Care

Wound Care Center Application from MedData

Wound Care Center Application from MedData

Proper care of diabetic foot infections can save limbs, lives

Proper care of diabetic foot infections can save limbs, lives

New evidence behind WOUNDCHEK Protease Status to be presented at EWMA conference

New evidence behind WOUNDCHEK Protease Status to be presented at EWMA conference

Derma Sciences first quarter net sales increase 6% to $15.3 million

Derma Sciences first quarter net sales increase 6% to $15.3 million

Celleration initiates enrollment in MIST Therapy study for VLU

Celleration initiates enrollment in MIST Therapy study for VLU

EO2 Concepts added to Marathon Medical's FSS contract

EO2 Concepts added to Marathon Medical's FSS contract

Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial

Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial

NAWC introduces Wound Care Advisor journal

NAWC introduces Wound Care Advisor journal

3M Health Care honored with Silver Edison Awards

3M Health Care honored with Silver Edison Awards

Derma Sciences closes underwritten registered direct offering

Derma Sciences closes underwritten registered direct offering

FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.